| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | Australia | 4 | |
| #3 | Canada | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | United States | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Measuring microorganism processes | |
| #3 | Medical preparations | |
| #4 | Heterocyclic compounds | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Barberis Alcide | 14 |
| #2 | Berset Catherine | 10 |
| #3 | Gunde Tea | 9 |
| #4 | Traxler Peter | 7 |
| #5 | Tietz Julia | 7 |
| #6 | Schumacher Andreas | 7 |
| #7 | Audetat Stephan | 6 |
| #8 | Cottier Valerie | 5 |
| #9 | Luethi Urs | 5 |
| #10 | Capraro Hans-Georg | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2010083617A1 | Pyrazolopyrimidines as protein kinase inhibitors | |
| EP2025678A1 | Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase | |
| EP1901748A1 | Angiogenesis inhibitors | |
| AU2005336856A1 | Genetic selection system to identify proteases, protease substrates and protease inhibitors | |
| EP1675961A1 | Method for the identification and/or validation of receptor tyrosine kinase inhibitors |